Home >> Diseases & Conditions >> Government >> Food & Beverage >>

Hepatitis B Global Clinical Trials Review, H2, 2014

Published: Nov-2014 | Format: PDF | GlobalData | Number of pages: 134 | Code: MRS - 1793

GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2014"" provides data on the Hepatitis B clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis B. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis B. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hepatitis B 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hepatitis B to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hepatitis B 25
Subjects Recruited Over a Period of Time 33
Clinical Trials by Sponsor Type 34
Prominent Sponsors 35
Top Companies Participating in Hepatitis B Therapeutics Clinical Trials 36
Prominent Drugs 38
Latest Clinical Trials News on Hepatitis B 39
Nov 10, 2014: TetraLogic Pharmaceuticals Announces Results Of Preclinical Studies In Hepatitis B 39
Nov 10, 2014: Novira Therapeutics Announces Presentation of Phase 1a Safety and Pharmacokinetic Data for NVR 3-778 39
Nov 10, 2014: Dynavax Announces Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B 40
Oct 21, 2014: Hepatera Announces Proof-of-Concept Clinical Results with Myrcludex B, a Novel Entry Inhibitor for Treatment of Chronic Hepatitis B and Delta 40
Oct 15, 2014: Tekmira Presents Results Of Preclinical Studies With Hepatitis B Therapeutic 41
Oct 09, 2014: Tekmira to Present HBV Pre-Clinical Data at Meeting of the Oligonucleotide Therapeutics Society 41
Oct 08, 2014: Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver Meeting 2014 42
Oct 07, 2014: REPLICor to Present Updated Clinical Trial Data of REP-9-AC at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) 42
Oct 01, 2014: REPLICor announces initiation of its Phase II clinical trial with REP 2139-Ca in combination with Pegasys in patients with hepatitis B / hepatitis D co-infection 43
Sep 25, 2014: Radiant Research/Clinical Research Advantage Enrolls More Than 8,000 Subjects for Hepatitis B Vaccine Study 43
Sep 22, 2014: Dynavax Completes Enrollment of Phase 3 Study of HEPLISAV-B 44
Sep 04, 2014: Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies 44
Aug 27, 2014: TetraLogic Pharmaceuticals to Present Data From Pre-Clinical Studies With Hepatitis B at the 2014 International Meeting on Molecular Biology of Hepatitis B Viruses 45
Aug 27, 2014: Green Cross Initiates Phase II Trial of Investigational Recombinant Hepatitis B Immune Globulin 45
Clinical Trial Profiles 46
Clinical Trial Overview of Top Companies 46
GlaxoSmithKline plc 46
Clinical Trial Overview of GlaxoSmithKline plc 46
Gilead Sciences, Inc. 57
Clinical Trial Overview of Gilead Sciences, Inc. 57
F. Hoffmann-La Roche Ltd. 63
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 63
Merck & Co., Inc. 68
Clinical Trial Overview of Merck & Co., Inc. 68
Bristol-Myers Squibb Company 71
Clinical Trial Overview of Bristol-Myers Squibb Company 71
Novartis AG 74
Clinical Trial Overview of Novartis AG 74
Sanofi 77
Clinical Trial Overview of Sanofi 77
Bukwang Pharm.Co., Ltd. 80
Clinical Trial Overview of Bukwang Pharm.Co., Ltd. 80
Dynavax Technologies Corporation 82
Clinical Trial Overview of Dynavax Technologies Corporation 82
LG Life Sciences, Ltd. 83
Clinical Trial Overview of LG Life Sciences, Ltd. 83
Clinical Trial Overview of Top Institutes / Government 84
National Taiwan University Hospital 84
Clinical Trial Overview of National Taiwan University Hospital 84
The National Institute of Diabetes and Digestive and Kidney Diseases 86
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 86
The National Institute of Allergy and Infectious Diseases 87
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 87
Sun Yat-sen University 88
Clinical Trial Overview of Sun Yat-sen University 88
Third Affiliated Hospital of Sun Yat-sen University 89
Clinical Trial Overview of Third Affiliated Hospital of Sun Yat-sen University 89
Yonsei University 90
Clinical Trial Overview of Yonsei University 90
The Foundation for Liver Research 91
Clinical Trial Overview of The Foundation for Liver Research 91
Chinese University of Hong Kong 92
Clinical Trial Overview of Chinese University of Hong Kong 92
The University of Hong Kong 93
Clinical Trial Overview of The University of Hong Kong 93
French National Agency for Research on AIDS and Viral Hepatitis 94
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 94
Five Key Clinical Profiles 95

Appendix 132
Abbreviations 132
Definitions 132
Research Methodology 133
Secondary Research 133
About GlobalData 134
Contact Us 134
Disclaimer 134
Source 134

List of Tables


Hepatitis B Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hepatitis B Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hepatitis B Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hepatitis B Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Hepatitis B Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Hepatitis B Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 33
Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 34
Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 35
Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 46
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 57
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 63
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 68
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 71
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 74
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 77
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Bukwang Pharm.Co., Ltd., 2014* 80
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Dynavax Technologies Corporation, 2014* 82
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2014* 83
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 84
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 86
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 87
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 88
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Affiliated Hospital of Sun Yat-sen University, 2014* 89
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014* 90
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The Foundation for Liver Research, 2014* 91
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 92
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 93
Hepatitis B Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014* 94

List of Figures


Hepatitis B Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hepatitis B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hepatitis B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Hepatitis B Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hepatitis B Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hepatitis B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Hepatitis B Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Hepatitis B to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hepatitis B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hepatitis B to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hepatitis B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hepatitis B Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Hepatitis B Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hepatitis B Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hepatitis B Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hepatitis B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 33
Hepatitis B Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 34
Hepatitis B Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 35
Hepatitis B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Hepatitis B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
GlobalData Methodology 133

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing